These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3722363)

  • 21. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
    Treanor JJ; Roth FK; Betts RF
    J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines.
    Murphy BR; Tierney EL; Barbour BA; Yolken RH; Alling DW; Holley HP; Mayner RE; Chanock RM
    Infect Immun; 1980 Aug; 29(2):342-7. PubMed ID: 7011972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.
    Clements ML; Betts RF; Tierney EL; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):73-6. PubMed ID: 3700611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.
    Murphy BR; Nelson DL; Wright PF; Tierney EL; Phelan MA; Chanock RM
    Infect Immun; 1982 Jun; 36(3):1102-8. PubMed ID: 7095844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.
    Chen KS; Burlington DB; Quinnan GV
    J Virol; 1987 Jul; 61(7):2150-4. PubMed ID: 3586130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Wells J; Arden N; Niño D; Belmont JW
    J Infect Dis; 2013 Mar; 207(6):974-81. PubMed ID: 23307936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin-specific radioimmunoprecipitation assays for quantitation of nasal secretory antibodies to hemagglutinin of type A influenza viruses.
    Kasel JA; Six HR; Oborn CJ; Dreesman GR
    J Clin Microbiol; 1978 Aug; 8(2):171-6. PubMed ID: 100506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.
    Powers DC; Kilbourne ED; Johansson BE
    Clin Diagn Lab Immunol; 1996 Sep; 3(5):511-6. PubMed ID: 8877127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children.
    Burlington DB; Wright PF; van Wyke KL; Phelan MA; Mayner RE; Murphy BR
    J Clin Microbiol; 1985 May; 21(5):847-9. PubMed ID: 3839001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A.
    Hocart MJ; Mackenzie JS; Stewart GA
    J Med Virol; 1990 Feb; 30(2):92-6. PubMed ID: 2313275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers.
    Yamane N; Nakamura Y; Yuki M; Odagiri T; Ishida N
    J Hyg (Lond); 1984 Apr; 92(2):231-42. PubMed ID: 6707472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.
    Steinhoff MC; Fries LF; Karron RA; Clements ML; Murphy BR
    J Clin Microbiol; 1993 Apr; 31(4):836-8. PubMed ID: 8463393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine.
    Clements ML; Tierney EL; Murphy BR
    J Clin Microbiol; 1985 Jun; 21(6):997-9. PubMed ID: 4008629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL
    Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.